These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36768182)

  • 1. Combination Treatment of a Phytochemical and a Histone Demethylase Inhibitor-A Novel Approach towards Targeting TGFβ-Induced EMT, Invasion, and Migration in Prostate Cancer.
    Dalpatraj N; Naik A; Thakur N
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GSK-J4 on JMJD3 Histone Demethylase in Mouse Prostate Cancer Xenografts.
    Sanchez A; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
    Cancer Genomics Proteomics; 2022; 19(3):339-349. PubMed ID: 35430567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
    Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
    Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells.
    Sui A; Xu Y; Li Y; Hu Q; Wang Z; Zhang H; Yang J; Guo X; Zhao W
    Oncotarget; 2017 Sep; 8(40):68591-68598. PubMed ID: 28978140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase KDM6B promotes epithelial-mesenchymal transition.
    Ramadoss S; Chen X; Wang CY
    J Biol Chem; 2012 Dec; 287(53):44508-17. PubMed ID: 23152497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Chen D; Cai B; Zhu Y; Ma Y; Yu X; Xiong J; Shen J; Tie W; Zhang Y; Guo F
    Clin Epigenetics; 2024 Apr; 16(1):51. PubMed ID: 38576048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
    Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
    Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of KDM6A and KDM6B, as a novel therapeutic strategy for treating craniosynostosis in Saethre-Chotzen syndrome.
    Pribadi C; Camp E; Cakouros D; Anderson P; Glackin C; Gronthos S
    Stem Cell Res Ther; 2020 Dec; 11(1):529. PubMed ID: 33298158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
    Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase JMJD3 regulates fibroblast-like synoviocyte-mediated proliferation and joint destruction in rheumatoid arthritis.
    Jia W; Wu W; Yang D; Xiao C; Su Z; Huang Z; Li Z; Qin M; Huang M; Liu S; Long F; Mao J; Liu X; Zhu YZ
    FASEB J; 2018 Jul; 32(7):4031-4042. PubMed ID: 29481307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA sequencing reveals resistance of TLR4 ligand-activated microglial cells to inflammation mediated by the selective jumonji H3K27 demethylase inhibitor.
    Das A; Arifuzzaman S; Yoon T; Kim SH; Chai JC; Lee YS; Jung KH; Chai YG
    Sci Rep; 2017 Jul; 7(1):6554. PubMed ID: 28747667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs.
    Doñas C; Carrasco M; Fritz M; Prado C; Tejón G; Osorio-Barrios F; Manríquez V; Reyes P; Pacheco R; Bono MR; Loyola A; Rosemblatt M
    J Autoimmun; 2016 Dec; 75():105-117. PubMed ID: 27528513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression.
    Yu C; Xiong C; Tang J; Hou X; Liu N; Bayliss G; Zhuang S
    Theranostics; 2021; 11(6):2706-2721. PubMed ID: 33456568
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
    Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR
    Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells.
    Cribbs A; Hookway ES; Wells G; Lindow M; Obad S; Oerum H; Prinjha RK; Athanasou N; Sowman A; Philpott M; Penn H; Soderstrom K; Feldmann M; Oppermann U
    J Biol Chem; 2018 Feb; 293(7):2422-2437. PubMed ID: 29301935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jumonji domain containing-3 (JMJD3) inhibition attenuates IL-1β-induced chondrocytes damage in vitro and protects osteoarthritis cartilage in vivo.
    Jun Z; Xinmeng J; Yue L; Zhi W; Yan Z; Tieyi Y; Jiangan T
    Inflamm Res; 2020 Jul; 69(7):657-666. PubMed ID: 32394143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.